NOAEL Studies
Cosmetic Ingredient
Sodium Heparin NOAEL Studies
INCI: SODIUM HEPARIN
CAS: 9041-08-1
Raw No Observed Adverse Effect Level endpoint records grouped by source. This page does not render calculated Margin of Safety values.
FDA 24 endpoints
| Source | Endpoint Type | Value | Unit | Species | Route | Duration | Study Type | Reference |
|---|---|---|---|---|---|---|---|---|
| FDA | NOAEL | =4 | mg/kg bw/day | rat (Sprague-Dawley; male/female) | subcutaneous | 1 year | repeated dose toxicity other | 040515be-0912-43d8-ab26-eeb1669a191e_dossier.i6z - RepeatedDoseToxicityOther - 1-year chronic toxicity study in the rats followed by a 6-week reversibility period_89/NLP031/0142 - 1ed4089b-6f8d-4190-a7fe-1caf84208a6f/fdbd24bc-b02a-43ef-b071-3887e95dec95 - basis: other: |
| FDA | NOAEL | =4 | mg/kg bw/day | rat (Sprague-Dawley; male/female) | subcutaneous | 1 year | repeated dose toxicity other | 040515be-0912-43d8-ab26-eeb1669a191e_dossier.i6z - RepeatedDoseToxicityOther - 1-year chronic toxicity study in the rats followed by a 6-week reversibility period_89/NLP031/0142 - 1ed4089b-6f8d-4190-a7fe-1caf84208a6f/fdbd24bc-b02a-43ef-b071-3887e95dec95 - basis: other: |
| FDA | NOAEL | =4 | mg/kg bw/day | rat (Sprague-Dawley; male/female) | subcutaneous | 1 year | repeated dose toxicity other | 040515be-0912-43d8-ab26-eeb1669a191e_dossier.i6z - RepeatedDoseToxicityOther - 1-year chronic toxicity study in the rats followed by a 6-week reversibility period_89/NLP031/0142 - 1ed4089b-6f8d-4190-a7fe-1caf84208a6f/fdbd24bc-b02a-43ef-b071-3887e95dec95 - basis: other: |
| FDA | NOAEL | =4 | mg/kg bw/day | rat (Sprague-Dawley; male/female) | subcutaneous | 1 year | repeated dose toxicity other | 040515be-0912-43d8-ab26-eeb1669a191e_dossier.i6z - RepeatedDoseToxicityOther - 1-year chronic toxicity study in the rats followed by a 6-week reversibility period_89/NLP031/0142 - 1ed4089b-6f8d-4190-a7fe-1caf84208a6f/fdbd24bc-b02a-43ef-b071-3887e95dec95 - basis: other: |
| FDA | NOAEL | =10 | mg/kg bw/day | dog (Beagle; male/female) | subcutaneous | 1 year | repeated dose toxicity other | 040515be-0912-43d8-ab26-eeb1669a191e_dossier.i6z - RepeatedDoseToxicityOther - 1-year chronic subcutaneous toxicity study in beagle dogs_88/NLP026/0843 - da3c28ff-c5ae-445c-a938-5da5cc9e59eb/fdbd24bc-b02a-43ef-b071-3887e95dec95 - basis: other: |
| FDA | NOAEL | =10 | mg/kg bw/day | dog (Beagle; male/female) | subcutaneous | 1 year | repeated dose toxicity other | 040515be-0912-43d8-ab26-eeb1669a191e_dossier.i6z - RepeatedDoseToxicityOther - 1-year chronic subcutaneous toxicity study in beagle dogs_88/NLP026/0843 - da3c28ff-c5ae-445c-a938-5da5cc9e59eb/fdbd24bc-b02a-43ef-b071-3887e95dec95 - basis: other: |
| FDA | NOAEL | =10 | mg/kg bw/day | dog (Beagle; male/female) | subcutaneous | 1 year | repeated dose toxicity other | 040515be-0912-43d8-ab26-eeb1669a191e_dossier.i6z - RepeatedDoseToxicityOther - 1-year chronic subcutaneous toxicity study in beagle dogs_88/NLP026/0843 - da3c28ff-c5ae-445c-a938-5da5cc9e59eb/fdbd24bc-b02a-43ef-b071-3887e95dec95 - basis: other: |
| FDA | NOAEL | =10 | mg/kg bw/day | dog (Beagle; male/female) | subcutaneous | 1 year | repeated dose toxicity other | 040515be-0912-43d8-ab26-eeb1669a191e_dossier.i6z - RepeatedDoseToxicityOther - 1-year chronic subcutaneous toxicity study in beagle dogs_88/NLP026/0843 - da3c28ff-c5ae-445c-a938-5da5cc9e59eb/fdbd24bc-b02a-43ef-b071-3887e95dec95 - basis: other: |
| FDA | NOEL | <=25 | mg/kg bw/day | rat (Sprague-Dawley; male/female) | intravenous | GD 7-17 | developmental toxicity teratogenicity | 040515be-0912-43d8-ab26-eeb1669a191e_dossier.i6z - DevelopmentalToxicityTeratogenicity - Segment II: intravenous teratology study in the rat_92/NLP150/0828 - 176a19f5-e6ab-4a06-a4c6-a3e2ff6208b2/fdbd24bc-b02a-43ef-b071-3887e95dec95 - basis: body weight and weight gain: no abnormal phenotype detected |
| FDA | NOEL | <=25 | mg/kg bw/day | rat (Sprague-Dawley; male/female) | intravenous | GD 7-17 | developmental toxicity teratogenicity | 040515be-0912-43d8-ab26-eeb1669a191e_dossier.i6z - DevelopmentalToxicityTeratogenicity - Segment II: intravenous teratology study in the rat_92/NLP150/0828 - 176a19f5-e6ab-4a06-a4c6-a3e2ff6208b2/fdbd24bc-b02a-43ef-b071-3887e95dec95 - basis: body weight and weight gain: no abnormal phenotype detected |
| FDA | NOEL | <=25 | mg/kg bw/day | rat (Sprague-Dawley; male/female) | intravenous | GD 7-17 | developmental toxicity teratogenicity | 040515be-0912-43d8-ab26-eeb1669a191e_dossier.i6z - DevelopmentalToxicityTeratogenicity - Segment II: intravenous teratology study in the rat_92/NLP150/0828 - 176a19f5-e6ab-4a06-a4c6-a3e2ff6208b2/fdbd24bc-b02a-43ef-b071-3887e95dec95 - basis: body weight and weight gain: no abnormal phenotype detected |
| FDA | NOEL | <=25 | mg/kg bw/day | rat (Sprague-Dawley; male/female) | intravenous | GD 7-17 | developmental toxicity teratogenicity | 040515be-0912-43d8-ab26-eeb1669a191e_dossier.i6z - DevelopmentalToxicityTeratogenicity - Segment II: intravenous teratology study in the rat_92/NLP150/0828 - 176a19f5-e6ab-4a06-a4c6-a3e2ff6208b2/fdbd24bc-b02a-43ef-b071-3887e95dec95 - basis: body weight and weight gain: no abnormal phenotype detected |
| FDA | NOEL | <=50 | mg/kg bw/day | rat (Sprague-Dawley; male/female) | intravenous | M: 71d premating; F: 15d premating - LD 4 | reproductive toxicity | 040515be-0912-43d8-ab26-eeb1669a191e_dossier.i6z - ToxicityReproduction - Segment I: intravenous fertility and reproductive performance study in the rat_92/NLP137/0528 - ca9fb644-8b8d-47f3-b2b1-b88f99803eae/fdbd24bc-b02a-43ef-b071-3887e95dec95 - basis: reproductive function (oestrous cycle): no abnormal phenotype detected |
| FDA | NOEL | <=50 | mg/kg bw/day | rat (Sprague-Dawley; male/female) | intravenous | M: 71d premating; F: 15d premating - LD 4 | reproductive toxicity | 040515be-0912-43d8-ab26-eeb1669a191e_dossier.i6z - ToxicityReproduction - Segment I: intravenous fertility and reproductive performance study in the rat_92/NLP137/0528 - ca9fb644-8b8d-47f3-b2b1-b88f99803eae/fdbd24bc-b02a-43ef-b071-3887e95dec95 - basis: reproductive function (oestrous cycle): no abnormal phenotype detected |
| FDA | NOEL | <=50 | mg/kg bw/day | rat (Sprague-Dawley; male/female) | intravenous | M: 71d premating; F: 15d premating - LD 4 | reproductive toxicity | 040515be-0912-43d8-ab26-eeb1669a191e_dossier.i6z - ToxicityReproduction - Segment I: intravenous fertility and reproductive performance study in the rat_92/NLP137/0528 - ca9fb644-8b8d-47f3-b2b1-b88f99803eae/fdbd24bc-b02a-43ef-b071-3887e95dec95 - basis: reproductive function (oestrous cycle): no abnormal phenotype detected |
| FDA | NOEL | <=50 | mg/kg bw/day | rat (Sprague-Dawley; male/female) | intravenous | M: 71d premating; F: 15d premating - LD 4 | reproductive toxicity | 040515be-0912-43d8-ab26-eeb1669a191e_dossier.i6z - ToxicityReproduction - Segment I: intravenous fertility and reproductive performance study in the rat_92/NLP137/0528 - ca9fb644-8b8d-47f3-b2b1-b88f99803eae/fdbd24bc-b02a-43ef-b071-3887e95dec95 - basis: reproductive function (oestrous cycle): no abnormal phenotype detected |
| FDA | NOEL | <=75 | mg/kg bw/day | rat (Sprague-Dawley; male/female) | intravenous | GD 7-17 | developmental toxicity teratogenicity | 040515be-0912-43d8-ab26-eeb1669a191e_dossier.i6z - DevelopmentalToxicityTeratogenicity - Segment II: intravenous teratology study in the rat_92/NLP138/0361 - 89ee173f-377a-4342-abe9-3a11c12b9f70/fdbd24bc-b02a-43ef-b071-3887e95dec95 - basis: food consumption and compound intake: no abnormal phenotype detected |
| FDA | NOEL | <=75 | mg/kg bw/day | rat (Sprague-Dawley; male/female) | intravenous | GD 7-17 | developmental toxicity teratogenicity | 040515be-0912-43d8-ab26-eeb1669a191e_dossier.i6z - DevelopmentalToxicityTeratogenicity - Segment II: intravenous teratology study in the rat_92/NLP138/0361 - 89ee173f-377a-4342-abe9-3a11c12b9f70/fdbd24bc-b02a-43ef-b071-3887e95dec95 - basis: food consumption and compound intake: no abnormal phenotype detected |
| FDA | NOEL | <=75 | mg/kg bw/day | rat (Sprague-Dawley; male/female) | intravenous | GD 7-17 | developmental toxicity teratogenicity | 040515be-0912-43d8-ab26-eeb1669a191e_dossier.i6z - DevelopmentalToxicityTeratogenicity - Segment II: intravenous teratology study in the rat_92/NLP138/0361 - 89ee173f-377a-4342-abe9-3a11c12b9f70/fdbd24bc-b02a-43ef-b071-3887e95dec95 - basis: food consumption and compound intake: no abnormal phenotype detected |
| FDA | NOEL | <=75 | mg/kg bw/day | rat (Sprague-Dawley; male/female) | intravenous | GD 7-17 | developmental toxicity teratogenicity | 040515be-0912-43d8-ab26-eeb1669a191e_dossier.i6z - DevelopmentalToxicityTeratogenicity - Segment II: intravenous teratology study in the rat_92/NLP138/0361 - 89ee173f-377a-4342-abe9-3a11c12b9f70/fdbd24bc-b02a-43ef-b071-3887e95dec95 - basis: food consumption and compound intake: no abnormal phenotype detected |
| FDA | NOEL | <=100 | mg/kg bw/day | rat (Wistar; male/female) | intravenous | 28 days | repeated dose toxicity other | 040515be-0912-43d8-ab26-eeb1669a191e_dossier.i6z - RepeatedDoseToxicityOther - 4-week intravenous toxicology study in rats_5785 - dcbe18e1-6d7f-46da-8d37-f9616ae2bc31/fdbd24bc-b02a-43ef-b071-3887e95dec95 - basis: body weight and weight gain: no abnormal phenotype detected |
| FDA | NOEL | <=100 | mg/kg bw/day | rat (Wistar; male/female) | intravenous | 28 days | repeated dose toxicity other | 040515be-0912-43d8-ab26-eeb1669a191e_dossier.i6z - RepeatedDoseToxicityOther - 4-week intravenous toxicology study in rats_5785 - dcbe18e1-6d7f-46da-8d37-f9616ae2bc31/fdbd24bc-b02a-43ef-b071-3887e95dec95 - basis: body weight and weight gain: no abnormal phenotype detected |
| FDA | NOEL | <=100 | mg/kg bw/day | rat (Wistar; male/female) | intravenous | 28 days | repeated dose toxicity other | 040515be-0912-43d8-ab26-eeb1669a191e_dossier.i6z - RepeatedDoseToxicityOther - 4-week intravenous toxicology study in rats_5785 - dcbe18e1-6d7f-46da-8d37-f9616ae2bc31/fdbd24bc-b02a-43ef-b071-3887e95dec95 - basis: body weight and weight gain: no abnormal phenotype detected |
| FDA | NOEL | <=100 | mg/kg bw/day | rat (Wistar; male/female) | intravenous | 28 days | repeated dose toxicity other | 040515be-0912-43d8-ab26-eeb1669a191e_dossier.i6z - RepeatedDoseToxicityOther - 4-week intravenous toxicology study in rats_5785 - dcbe18e1-6d7f-46da-8d37-f9616ae2bc31/fdbd24bc-b02a-43ef-b071-3887e95dec95 - basis: body weight and weight gain: no abnormal phenotype detected |
ECHA 8 endpoints
| Source | Endpoint Type | Value | Unit | Species | Route | Duration | Study Type | Reference |
|---|---|---|---|---|---|---|---|---|
| ECHA | LEL | >=4 | mg/kg bw/day | Dog | injection | chronic; 52 weeks | chronic | STORED_SOURCE_RECORD=https://clowder.edap-cluster.com/files/67c62006e4b096bca877fb06; RECORD_SOURCE_LEVEL=Extraction document; SOURCE_URL=https://echa.europa.eu/; SUBSOURCE_URL=https://iuclid6.echa.europa.eu/us-fda-toxicity-data?documentUUID=fdbd24bc-b02a-43ef-b071-3887e95dec95; TOXICOLOGICAL_EFFECT=enlarged spleen|infusion site swelling|injection site changes|injection site discoloration|injection site induration|injection site inflammation|injection site scab; STUDY_GROUP=ECHA IUCLID_dup_Repeated Dose Toxicity Other_15851284_15851285:M/F:--; QC_CATEGORY=Programmatically extracted from structured data source; Source overall passed QC, but this record was not manually checked; QC_STATUS=not determined; SOURCE_HASH=ToxValhc_000fd04460cf7e1ee6f8dc890be70d79 |
| ECHA | LEL | >=5 | mg/kg bw/day | Rat | injection | chronic; 26 weeks | chronic | STORED_SOURCE_RECORD=https://clowder.edap-cluster.com/files/67c620e3e4b096bca87830a5; RECORD_SOURCE_LEVEL=Extraction document; SOURCE_URL=https://echa.europa.eu/; SUBSOURCE_URL=https://iuclid6.echa.europa.eu/us-fda-toxicity-data?documentUUID=fdbd24bc-b02a-43ef-b071-3887e95dec95; TOXICOLOGICAL_EFFECT=decreased circulating serum albumin level|increased circulating globulin level|infusion site swelling|injection site changes|injection site inflammation|injection site scab; STUDY_GROUP=ECHA IUCLID_dup_Repeated Dose Toxicity Other_15854316_15854317_15854319:M/F:--; QC_CATEGORY=Programmatically extracted from structured data source; Source overall passed QC, but this record was not manually checked; QC_STATUS=not determined; SOURCE_HASH=ToxValhc_51560d5319bef915ad3ea93f870f3a6b |
| ECHA | LEL | >=10 | mg/kg bw/day | Rat | injection | chronic; 1 years | chronic | STORED_SOURCE_RECORD=https://clowder.edap-cluster.com/files/67c62006e4b096bca877fbba; RECORD_SOURCE_LEVEL=Extraction document; SOURCE_URL=https://echa.europa.eu/; SUBSOURCE_URL=https://iuclid6.echa.europa.eu/us-fda-toxicity-data?documentUUID=fdbd24bc-b02a-43ef-b071-3887e95dec95; TOXICOLOGICAL_EFFECT=increased kidney weight|increased liver weight|increased spleen weight; TOXICOLOGICAL_EFFECT_CATEGORY=organ weight; STUDY_GROUP=ECHA IUCLID_dup_Repeated Dose Toxicity Other_15851504_15851505_15851506_15851508_15851509:M/F:--; QC_CATEGORY=Programmatically extracted from structured data source; Source overall passed QC, but this record was not manually checked; QC_STATUS=not determined; SOURCE_HASH=ToxValhc_d74f81af716a881fd6b7c765b48734cc |
| ECHA | LEL | =30 | mg/kg bw/day | Dog | injection | short-term; 28 days | short-term | STORED_SOURCE_RECORD=https://clowder.edap-cluster.com/files/67c6206ae4b096bca87814ac; RECORD_SOURCE_LEVEL=Extraction document; SOURCE_URL=https://echa.europa.eu/; SUBSOURCE_URL=https://iuclid6.echa.europa.eu/us-fda-toxicity-data?documentUUID=fdbd24bc-b02a-43ef-b071-3887e95dec95; TOXICOLOGICAL_EFFECT=increased circulating creatinine level; STUDY_GROUP=ECHA IUCLID:15852963:M:--; QC_CATEGORY=Programmatically extracted from structured data source; Source overall passed QC, but this record was not manually checked; QC_STATUS=not determined; SOURCE_HASH=ToxValhc_24405ccb831d24f2d61def0fa7d37d97 |
| ECHA | LEL | =100 | mg/kg bw/day | Rat | injection | short-term; 28 days | short-term | STORED_SOURCE_RECORD=https://clowder.edap-cluster.com/files/67c620d2e4b096bca8782e01; RECORD_SOURCE_LEVEL=Extraction document; SOURCE_URL=https://echa.europa.eu/; SUBSOURCE_URL=https://iuclid6.echa.europa.eu/us-fda-toxicity-data?documentUUID=fdbd24bc-b02a-43ef-b071-3887e95dec95; TOXICOLOGICAL_EFFECT=decreased circulating potassium level; STUDY_GROUP=ECHA IUCLID:15854290:M:--; QC_CATEGORY=Programmatically extracted from structured data source; Source overall passed QC, but this record was not manually checked; QC_STATUS=not determined; SOURCE_HASH=ToxValhc_7040f1fb198a60e69040384de6caaea2 |
| ECHA | NOAEL | >=10 | mg/kg bw/day | Rat | injection | - | reproduction developmental | QUALITY=2 (reliable with restrictions); STORED_SOURCE_RECORD=https://clowder.edap-cluster.com/files/66a7d199e4b0a7c65d22f3cd; RECORD_SOURCE_LEVEL=Extraction document; SOURCE_URL=https://echa.europa.eu/; SUBSOURCE_URL=https://echa.europa.eu/en/registration-dossier/-/registered-dossier/11634?documentUUID=8a921886-e6d5-496f-982c-45f56237b782; YEAR=1997; ORIGINAL_YEAR=1997; STUDY_GROUP=ECHA IUCLID:15822443:F:-maternal; QC_CATEGORY=Programmatically extracted from structured data source; Source overall passed QC, but this record was not manually checked; QC_STATUS=not determined; SOURCE_HASH=ToxValhc_30039af1e1a6c2676b50666593433464 |
| ECHA | NOEL | <=25 | mg/kg bw/day | Dog | injection | chronic; 52 weeks | chronic | STORED_SOURCE_RECORD=https://clowder.edap-cluster.com/files/67c62006e4b096bca877fb06; RECORD_SOURCE_LEVEL=Extraction document; SOURCE_URL=https://echa.europa.eu/; SUBSOURCE_URL=https://iuclid6.echa.europa.eu/us-fda-toxicity-data?documentUUID=fdbd24bc-b02a-43ef-b071-3887e95dec95; TOXICOLOGICAL_EFFECT=no abnormal phenotype detected; STUDY_GROUP=ECHA IUCLID_dup_Repeated Dose Toxicity Other_15851284_15851285:M/F:--; QC_CATEGORY=Programmatically extracted from structured data source; Source overall passed QC, but this record was not manually checked; QC_STATUS=not determined; SOURCE_HASH=ToxValhc_6970b08234494b9486d2b9ebaa5a737b |
| ECHA | NOEL | <=50 | mg/kg bw/day | Dog | injection | short-term; 28 days | short-term | STORED_SOURCE_RECORD=https://clowder.edap-cluster.com/files/67c6206ae4b096bca87814ac; RECORD_SOURCE_LEVEL=Extraction document; SOURCE_URL=https://echa.europa.eu/; SUBSOURCE_URL=https://iuclid6.echa.europa.eu/us-fda-toxicity-data?documentUUID=fdbd24bc-b02a-43ef-b071-3887e95dec95; TOXICOLOGICAL_EFFECT=no abnormal phenotype detected; STUDY_GROUP=ECHA IUCLID_dup_Repeated Dose Toxicity Other_15852961_15852962_15852964:M/F:--; QC_CATEGORY=Programmatically extracted from structured data source; Source overall passed QC, but this record was not manually checked; QC_STATUS=not determined; SOURCE_HASH=ToxValhc_412bfe38931801d227935e18c2b091aa |
openFDA substances 52 endpoints
| Source | Endpoint Type | Value | Unit | Species | Route | Duration | Study Type | Reference |
|---|---|---|---|---|---|---|---|---|
| openFDA substances | FDA UNII substance identifier | 12M44VTJ7B | UNII | - | - | - | polymer | {"approval_status":null,"molecular_formula":null,"source_table":"substance_identifiers_fda","substance_class":"polymer","unii_code":"12M44VTJ7B"} |
| openFDA substances | FDA UNII substance identifier | 12M44VTJ7B | UNII | - | - | - | polymer | {"approval_status":null,"molecular_formula":null,"source_table":"substance_identifiers_fda","substance_class":"polymer","unii_code":"12M44VTJ7B"} |
| openFDA substances | FDA UNII substance identifier | 12M44VTJ7B | UNII | - | - | - | polymer | {"approval_status":null,"molecular_formula":null,"source_table":"substance_identifiers_fda","substance_class":"polymer","unii_code":"12M44VTJ7B"} |
| openFDA substances | FDA UNII substance identifier | 12M44VTJ7B | UNII | - | - | - | polymer | {"approval_status":null,"molecular_formula":null,"source_table":"substance_identifiers_fda","substance_class":"polymer","unii_code":"12M44VTJ7B"} |
| openFDA substances | FDA UNII substance identifier | 19GW9E1WHN | UNII | - | - | - | polymer | {"approval_status":null,"molecular_formula":null,"source_table":"substance_identifiers_fda","substance_class":"polymer","unii_code":"19GW9E1WHN"} |
| openFDA substances | FDA UNII substance identifier | 19GW9E1WHN | UNII | - | - | - | polymer | {"approval_status":null,"molecular_formula":null,"source_table":"substance_identifiers_fda","substance_class":"polymer","unii_code":"19GW9E1WHN"} |
| openFDA substances | FDA UNII substance identifier | 19GW9E1WHN | UNII | - | - | - | polymer | {"approval_status":null,"molecular_formula":null,"source_table":"substance_identifiers_fda","substance_class":"polymer","unii_code":"19GW9E1WHN"} |
| openFDA substances | FDA UNII substance identifier | 19GW9E1WHN | UNII | - | - | - | polymer | {"approval_status":null,"molecular_formula":null,"source_table":"substance_identifiers_fda","substance_class":"polymer","unii_code":"19GW9E1WHN"} |
| openFDA substances | FDA UNII substance identifier | 3S182ET3UA | UNII | - | - | - | polymer | {"approval_status":null,"molecular_formula":null,"source_table":"substance_identifiers_fda","substance_class":"polymer","unii_code":"3S182ET3UA"} |
| openFDA substances | FDA UNII substance identifier | 3S182ET3UA | UNII | - | - | - | polymer | {"approval_status":null,"molecular_formula":null,"source_table":"substance_identifiers_fda","substance_class":"polymer","unii_code":"3S182ET3UA"} |
| openFDA substances | FDA UNII substance identifier | 3S182ET3UA | UNII | - | - | - | polymer | {"approval_status":null,"molecular_formula":null,"source_table":"substance_identifiers_fda","substance_class":"polymer","unii_code":"3S182ET3UA"} |
| openFDA substances | FDA UNII substance identifier | 3S182ET3UA | UNII | - | - | - | polymer | {"approval_status":null,"molecular_formula":null,"source_table":"substance_identifiers_fda","substance_class":"polymer","unii_code":"3S182ET3UA"} |
| openFDA substances | FDA UNII substance identifier | 4UTY6300OM | UNII | - | - | - | polymer | {"approval_status":null,"molecular_formula":null,"source_table":"substance_identifiers_fda","substance_class":"polymer","unii_code":"4UTY6300OM"} |
| openFDA substances | FDA UNII substance identifier | 4UTY6300OM | UNII | - | - | - | polymer | {"approval_status":null,"molecular_formula":null,"source_table":"substance_identifiers_fda","substance_class":"polymer","unii_code":"4UTY6300OM"} |
| openFDA substances | FDA UNII substance identifier | 4UTY6300OM | UNII | - | - | - | polymer | {"approval_status":null,"molecular_formula":null,"source_table":"substance_identifiers_fda","substance_class":"polymer","unii_code":"4UTY6300OM"} |
| openFDA substances | FDA UNII substance identifier | 4UTY6300OM | UNII | - | - | - | polymer | {"approval_status":null,"molecular_formula":null,"source_table":"substance_identifiers_fda","substance_class":"polymer","unii_code":"4UTY6300OM"} |
| openFDA substances | FDA UNII substance identifier | 5XQ9UBJ16W | UNII | - | - | - | polymer | {"approval_status":null,"molecular_formula":null,"source_table":"substance_identifiers_fda","substance_class":"polymer","unii_code":"5XQ9UBJ16W"} |
| openFDA substances | FDA UNII substance identifier | 5XQ9UBJ16W | UNII | - | - | - | polymer | {"approval_status":null,"molecular_formula":null,"source_table":"substance_identifiers_fda","substance_class":"polymer","unii_code":"5XQ9UBJ16W"} |
| openFDA substances | FDA UNII substance identifier | 5XQ9UBJ16W | UNII | - | - | - | polymer | {"approval_status":null,"molecular_formula":null,"source_table":"substance_identifiers_fda","substance_class":"polymer","unii_code":"5XQ9UBJ16W"} |
| openFDA substances | FDA UNII substance identifier | 5XQ9UBJ16W | UNII | - | - | - | polymer | {"approval_status":null,"molecular_formula":null,"source_table":"substance_identifiers_fda","substance_class":"polymer","unii_code":"5XQ9UBJ16W"} |
| openFDA substances | FDA UNII substance identifier | 6DZH9J3B27 | UNII | - | - | - | polymer | {"approval_status":null,"molecular_formula":null,"source_table":"substance_identifiers_fda","substance_class":"polymer","unii_code":"6DZH9J3B27"} |
| openFDA substances | FDA UNII substance identifier | 6DZH9J3B27 | UNII | - | - | - | polymer | {"approval_status":null,"molecular_formula":null,"source_table":"substance_identifiers_fda","substance_class":"polymer","unii_code":"6DZH9J3B27"} |
| openFDA substances | FDA UNII substance identifier | 6DZH9J3B27 | UNII | - | - | - | polymer | {"approval_status":null,"molecular_formula":null,"source_table":"substance_identifiers_fda","substance_class":"polymer","unii_code":"6DZH9J3B27"} |
| openFDA substances | FDA UNII substance identifier | 6DZH9J3B27 | UNII | - | - | - | polymer | {"approval_status":null,"molecular_formula":null,"source_table":"substance_identifiers_fda","substance_class":"polymer","unii_code":"6DZH9J3B27"} |
| openFDA substances | FDA UNII substance identifier | N3927D01PB | UNII | - | - | - | polymer | {"approval_status":null,"molecular_formula":null,"source_table":"substance_identifiers_fda","substance_class":"polymer","unii_code":"N3927D01PB"} |
| openFDA substances | FDA UNII substance identifier | N3927D01PB | UNII | - | - | - | polymer | {"approval_status":null,"molecular_formula":null,"source_table":"substance_identifiers_fda","substance_class":"polymer","unii_code":"N3927D01PB"} |
| openFDA substances | FDA UNII substance identifier | N3927D01PB | UNII | - | - | - | polymer | {"approval_status":null,"molecular_formula":null,"source_table":"substance_identifiers_fda","substance_class":"polymer","unii_code":"N3927D01PB"} |
| openFDA substances | FDA UNII substance identifier | N3927D01PB | UNII | - | - | - | polymer | {"approval_status":null,"molecular_formula":null,"source_table":"substance_identifiers_fda","substance_class":"polymer","unii_code":"N3927D01PB"} |
| openFDA substances | FDA UNII substance identifier | N816FF9P2W | UNII | - | - | - | polymer | {"approval_status":null,"molecular_formula":null,"source_table":"substance_identifiers_fda","substance_class":"polymer","unii_code":"N816FF9P2W"} |
| openFDA substances | FDA UNII substance identifier | N816FF9P2W | UNII | - | - | - | polymer | {"approval_status":null,"molecular_formula":null,"source_table":"substance_identifiers_fda","substance_class":"polymer","unii_code":"N816FF9P2W"} |
| openFDA substances | FDA UNII substance identifier | N816FF9P2W | UNII | - | - | - | polymer | {"approval_status":null,"molecular_formula":null,"source_table":"substance_identifiers_fda","substance_class":"polymer","unii_code":"N816FF9P2W"} |
| openFDA substances | FDA UNII substance identifier | N816FF9P2W | UNII | - | - | - | polymer | {"approval_status":null,"molecular_formula":null,"source_table":"substance_identifiers_fda","substance_class":"polymer","unii_code":"N816FF9P2W"} |
| openFDA substances | FDA UNII substance identifier | P59JKU02CE | UNII | - | - | - | polymer | {"approval_status":null,"molecular_formula":null,"source_table":"substance_identifiers_fda","substance_class":"polymer","unii_code":"P59JKU02CE"} |
| openFDA substances | FDA UNII substance identifier | P59JKU02CE | UNII | - | - | - | polymer | {"approval_status":null,"molecular_formula":null,"source_table":"substance_identifiers_fda","substance_class":"polymer","unii_code":"P59JKU02CE"} |
| openFDA substances | FDA UNII substance identifier | P59JKU02CE | UNII | - | - | - | polymer | {"approval_status":null,"molecular_formula":null,"source_table":"substance_identifiers_fda","substance_class":"polymer","unii_code":"P59JKU02CE"} |
| openFDA substances | FDA UNII substance identifier | P59JKU02CE | UNII | - | - | - | polymer | {"approval_status":null,"molecular_formula":null,"source_table":"substance_identifiers_fda","substance_class":"polymer","unii_code":"P59JKU02CE"} |
| openFDA substances | FDA UNII substance identifier | R5MB4B485P | UNII | - | - | - | polymer | {"approval_status":null,"molecular_formula":null,"source_table":"substance_identifiers_fda","substance_class":"polymer","unii_code":"R5MB4B485P"} |
| openFDA substances | FDA UNII substance identifier | R5MB4B485P | UNII | - | - | - | polymer | {"approval_status":null,"molecular_formula":null,"source_table":"substance_identifiers_fda","substance_class":"polymer","unii_code":"R5MB4B485P"} |
| openFDA substances | FDA UNII substance identifier | R5MB4B485P | UNII | - | - | - | polymer | {"approval_status":null,"molecular_formula":null,"source_table":"substance_identifiers_fda","substance_class":"polymer","unii_code":"R5MB4B485P"} |
| openFDA substances | FDA UNII substance identifier | R5MB4B485P | UNII | - | - | - | polymer | {"approval_status":null,"molecular_formula":null,"source_table":"substance_identifiers_fda","substance_class":"polymer","unii_code":"R5MB4B485P"} |
| openFDA substances | FDA UNII substance identifier | U6K360XMIU | UNII | - | - | - | polymer | {"approval_status":null,"molecular_formula":null,"source_table":"substance_identifiers_fda","substance_class":"polymer","unii_code":"U6K360XMIU"} |
| openFDA substances | FDA UNII substance identifier | U6K360XMIU | UNII | - | - | - | polymer | {"approval_status":null,"molecular_formula":null,"source_table":"substance_identifiers_fda","substance_class":"polymer","unii_code":"U6K360XMIU"} |
| openFDA substances | FDA UNII substance identifier | U6K360XMIU | UNII | - | - | - | polymer | {"approval_status":null,"molecular_formula":null,"source_table":"substance_identifiers_fda","substance_class":"polymer","unii_code":"U6K360XMIU"} |
| openFDA substances | FDA UNII substance identifier | U6K360XMIU | UNII | - | - | - | polymer | {"approval_status":null,"molecular_formula":null,"source_table":"substance_identifiers_fda","substance_class":"polymer","unii_code":"U6K360XMIU"} |
| openFDA substances | FDA UNII substance identifier | V5T10N50RD | UNII | - | - | - | polymer | {"approval_status":null,"molecular_formula":null,"source_table":"substance_identifiers_fda","substance_class":"polymer","unii_code":"V5T10N50RD"} |
| openFDA substances | FDA UNII substance identifier | V5T10N50RD | UNII | - | - | - | polymer | {"approval_status":null,"molecular_formula":null,"source_table":"substance_identifiers_fda","substance_class":"polymer","unii_code":"V5T10N50RD"} |
| openFDA substances | FDA UNII substance identifier | V5T10N50RD | UNII | - | - | - | polymer | {"approval_status":null,"molecular_formula":null,"source_table":"substance_identifiers_fda","substance_class":"polymer","unii_code":"V5T10N50RD"} |
| openFDA substances | FDA UNII substance identifier | V5T10N50RD | UNII | - | - | - | polymer | {"approval_status":null,"molecular_formula":null,"source_table":"substance_identifiers_fda","substance_class":"polymer","unii_code":"V5T10N50RD"} |
| openFDA substances | FDA UNII substance identifier | ZZ45AB24CA | UNII | - | - | - | polymer | {"approval_status":null,"molecular_formula":null,"source_table":"substance_identifiers_fda","substance_class":"polymer","unii_code":"ZZ45AB24CA"} |
| openFDA substances | FDA UNII substance identifier | ZZ45AB24CA | UNII | - | - | - | polymer | {"approval_status":null,"molecular_formula":null,"source_table":"substance_identifiers_fda","substance_class":"polymer","unii_code":"ZZ45AB24CA"} |
| openFDA substances | FDA UNII substance identifier | ZZ45AB24CA | UNII | - | - | - | polymer | {"approval_status":null,"molecular_formula":null,"source_table":"substance_identifiers_fda","substance_class":"polymer","unii_code":"ZZ45AB24CA"} |
| openFDA substances | FDA UNII substance identifier | ZZ45AB24CA | UNII | - | - | - | polymer | {"approval_status":null,"molecular_formula":null,"source_table":"substance_identifiers_fda","substance_class":"polymer","unii_code":"ZZ45AB24CA"} |